Jennifer Doudna: CRISPR Basics
Posted by btwatson on January 23, 2018 4:03 pm
Tags:
Categories:
Crispr
Jennifer Doudna: CRISPR Basics
Jennifer Doudna (University of California, Berkeley) explains the basics of CRISPR immunity, Cas9 mechanics, and anti-CRISPRs. [2017 CRISPR Workshop]
Crispr News
-
CRISPR Gene Detection and Diagnostic Market 2022-Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2028 – The Daily Vale - The Daily ValeMay 24, 2022
-
Gene Editing Service Market Size 2022 Overview by 2029 | Key Players – BBI Life Sciences, Bio Basic, CRISPR Therapeutics, Caribou Biosciences, DNA 2.0 (ATUM) – The Daily Vale - The Daily ValeMay 24, 2022
-
CRISPR Genome Editing Market 2022-2030, By Top Key Players – GE Healthcare Dharmcon, Transposagen, ToolGen, ThermoFisher Scientific, Agilent – The Daily Vale - The Daily ValeMay 24, 2022
-
Instability can benefit teams with different expertise - Verve TimesMay 24, 2022
-
Junior Party Broad Files Reply to Sigma-Aldrich Opposition to Substantive Preliminary Motion No. 1 in Interference No. 106,133 - JD SupraMay 23, 2022
-
Bacteria can live in snake and spider venoms — ScienceDaily - Verve TimesMay 23, 2022
-
New 'CRISPR-Combo' method boosts genome editing power in plants - Phys.orgMay 23, 2022
-
CRISPR, Xencor stock falls as Piper Sandler slashes price target in biotech space - Seeking AlphaMay 23, 2022
-
Gene-Edited Tomatoes: Scientists Use Crispr to Supply 'Sunshine Vitamin' - BloombergMay 23, 2022
-
CRISPR Editing Accidentally Turns Hamsters Into Angry Bullies - IFLScienceMay 23, 2022
-
Piper Sandler Maintains Overweight on CRISPR Therapeutics, Lowers Price Target to $115 - Benzinga - BenzingaMay 23, 2022
-
Lithotripters Market: Increasing Incidence of Urolithiasis to Drive the Market - BioSpaceMay 23, 2022
-
Gene Editing Technology Market to Witness Huge Growth by 2029 -Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agile - The Daily ValeMay 22, 2022
-
Epigenome Editing Decreases Alcohol Seeking and Anxiety in Rats - The ScientistMay 20, 2022
-
Science Paper on Spatial-Controlled Genome Editing - GenomeWebMay 20, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.